➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Colorcon
McKesson
Johnson and Johnson
Harvard Business School
Mallinckrodt
Express Scripts

Last Updated: June 16, 2021

DrugPatentWatch Database Preview

PEGINTRON Drug Profile


Email this page to a colleague

« Back to Dashboard

Summary for Tradename: PEGINTRON
Patents:33
Applicants:1
BLAs:1
Suppliers: see list1
Recent Clinical Trials: See clinical trials for PEGINTRON
Recent Clinical Trials for PEGINTRON

Identify potential brand extensions & biosimilar entrants

SponsorPhase
Third Affiliated Hospital, Sun Yat-Sen UniversityN/A
University of PennsylvaniaPhase 1
Philadelphia FightPhase 1

See all PEGINTRON clinical trials

Pharmacology for PEGINTRON
Ingredient-typeInterferon Alfa-2b
Interferon-alpha

Company Disclosures: US Patents for PEGINTRON

These patents were extracted from company disclosures
Glossary
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Schering PEGINTRON peginterferon alfa-2b VIAL 103949 001 2001-01-19   Get Started Free Schering Corporation (Kenilworth, NJ) 2015-11-02 RX company
Schering PEGINTRON peginterferon alfa-2b VIAL 103949 001 2001-01-19   Get Started Free Enzon, Inc. (Piscataway, NJ) 2013-11-10 RX company
Schering PEGINTRON peginterferon alfa-2b VIAL 103949 001 2001-01-19   Get Started Free Enzon, Inc. (Piscataway, NJ) 2013-11-10 RX company
Schering PEGINTRON peginterferon alfa-2b VIAL 103949 001 2001-01-19   Get Started Free Schering Corporation (Kenilworth, NJ) 2015-11-02 RX company
Schering PEGINTRON peginterferon alfa-2b VIAL 103949 001 2001-01-19   Get Started Free Schering Corporation (Kenilworth, NJ) 2018-03-26 RX company
Schering PEGINTRON peginterferon alfa-2b VIAL 103949 001 2001-01-19   Get Started Free Schering Corporation (Kenilworth, NJ) 2018-03-26 RX company
Schering PEGINTRON peginterferon alfa-2b VIAL 103949 001 2001-01-19   Get Started Free Hoffmann-La Roche Inc. (Nutley, NJ) Genentech, Inc. (South San Francisco, CA) 2019-11-19 RX company
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Subscribe to access the full database, or Get Started Free

Patent Text Search: US Patents for PEGINTRON

These patents were identified by searching patent claims
Glossary
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Schering PEGINTRON peginterferon alfa-2b VIAL 103949 001 2001-01-19   Get Started Free BAYER INTELLECTUAL PROPERTY GMBH (Monheim, DE) 2031-04-05 RX search
Schering PEGINTRON peginterferon alfa-2b VIAL 103949 001 2001-01-19   Get Started Free SIO2 MEDICAL PRODUCTS, INC. (Auburn, AL) 2029-05-13 RX search
Schering PEGINTRON peginterferon alfa-2b VIAL 103949 001 2001-01-19   Get Started Free 2040-03-24 RX search
Schering PEGINTRON peginterferon alfa-2b VIAL 103949 001 2001-01-19   Get Started Free ForSight Vision4, Inc. (South San Francisco, CA) 2029-01-29 RX search
Schering PEGINTRON peginterferon alfa-2b VIAL 103949 001 2001-01-19   Get Started Free Abbott Laboratories (Abbott Park, IL) 2023-03-24 RX search
Schering PEGINTRON peginterferon alfa-2b VIAL 103949 001 2001-01-19   Get Started Free Intermune, Inc. (Brisbane, CA) 2025-03-08 RX search
Schering PEGINTRON peginterferon alfa-2b VIAL 103949 001 2001-01-19   Get Started Free Roche Palo Alto LLC (Palo Alto, CA) 2039-02-26 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Subscribe to access the full database, or Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Moodys
McKesson
McKinsey
Merck
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2021 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2021 - 2022
 NCE-1 Patent Challenge Dates 2021 - 2022
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2021, www.DrugPatentWatch.com.

Links

Follow DrugPatentWatch:

  DrugPatentWatch Linkedin Group